Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway

[1]  A. Chédotal,et al.  Slit-Robo signaling , 2016, Development.

[2]  Mirang Kim,et al.  Specific expression and methylation of SLIT1, SLIT2, SLIT3, and miR-218 in gastric cancer subtypes. , 2016, International journal of oncology.

[3]  Y. Zhang,et al.  Effects of Slit3 silencing on the invasive ability of lung carcinoma A549 cells. , 2015, Oncology reports.

[4]  S. Monga.  β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis. , 2015, Gastroenterology.

[5]  Y. Hsieh,et al.  The differential roles of Slit2-exon 15 splicing variants in angiogenesis and HUVEC permeability , 2015, Angiogenesis.

[6]  T. Yau,et al.  Post-Operative Plasma Osteopontin Predicts Distant Metastasis in Human Colorectal Cancer , 2015, PloS one.

[7]  Jian-Jun Gu,et al.  miR-218 inhibits the migration and invasion of glioma U87 cells through the Slit2-Robo1 pathway , 2015, Oncology letters.

[8]  Jianmin Wu,et al.  Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling , 2014, International journal of cancer.

[9]  Bingya Liu,et al.  Knockdown of Slit2 promotes growth and motility in gastric cancer cells via activation of AKT/β-catenin. , 2014, Oncology reports.

[10]  T. Yau,et al.  The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance , 2013, PloS one.

[11]  D. Ly,et al.  β-Catenin knockdown in liver tumor cells by a cell permeable gamma guanidine-based peptide nucleic acid. , 2013, Current cancer drug targets.

[12]  W. Law,et al.  Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion , 2013, Hepatology.

[13]  L. Devoto,et al.  Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer , 2013, Molecular carcinogenesis.

[14]  H. Guan,et al.  Down-regulation of miR-218-2 and its host gene SLIT3 cooperate to promote invasion and progression of thyroid cancer. , 2013, The Journal of clinical endocrinology and metabolism.

[15]  Wei-feng Chen,et al.  SLIT2 inhibits cell migration in colorectal cancer through the AKT–GSK3β signaling pathway , 2013, International Journal of Colorectal Disease.

[16]  A. Bosserhoff,et al.  Fragments of SLIT3 inhibit cellular migration. , 2012, International journal of molecular medicine.

[17]  X. Xu,et al.  Frequent SLIT2 Promoter Methylation in the Serum of Patients with Ovarian Cancer , 2012, The Journal of international medical research.

[18]  S. Hillier,et al.  Glucocorticoid Regulation of SLIT/ROBO Tumour Suppressor Genes in the Ovarian Surface Epithelium and Ovarian Cancer Cells , 2011, PloS one.

[19]  J. Lee,et al.  Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients , 2011, Virchows Archiv.

[20]  Satdarshan P. S. Monga,et al.  Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-catenin. , 2011, Journal of hepatology.

[21]  Belinda E. Clarke,et al.  MicroRNA-218 Is Deleted and Downregulated in Lung Squamous Cell Carcinoma , 2010, PloS one.

[22]  D. Fan,et al.  MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor , 2010, PLoS genetics.

[23]  Jane Y. Wu,et al.  Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity. , 2009, Neuro-oncology.

[24]  Marc W. Kirschner,et al.  Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling , 2009, Nature.

[25]  Y. Takeda,et al.  Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma , 2009, British Journal of Cancer.

[26]  Yun Deng,et al.  Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas. , 2009, Biochemical and biophysical research communications.

[27]  O. Konu,et al.  Quantification of SLIT-ROBO transcripts in hepatocellular carcinoma reveals two groups of genes with coordinate expression , 2008, BMC Cancer.

[28]  C. Elmets,et al.  Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma. , 2008, Neoplasia.

[29]  S. Monga,et al.  R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells. , 2007, Journal of hepatology.

[30]  R. Zeillinger,et al.  The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells , 2007, Breast Cancer Research and Treatment.

[31]  I. Jurisica,et al.  Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling , 2006 .

[32]  C. Goparaju,et al.  Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression , 2006, Molecular Cancer.

[33]  I. Bièche,et al.  Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers , 2004, British Journal of Cancer.

[34]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[35]  A. Jemal,et al.  Global Cancer Statistics , 2011 .